Piperidine

Piperidine holds the distinction of being one of the most frequently occurring heterocycles in approved pharmaceuticals, present across a wider range of therapeutic areas than almost any other nitrogen-containing ring system. Piperidine is an extremely important building block in the synthesis of medicinal agents and has been employed variously as a CNS modulator, anticoagulant, antihistamine, anticancer agent, and analgesic. The saturated ring presents a basic nitrogen atom with a pKa of approximately 11, providing a hydrogen-bond donor and acceptor that supports engagement with a broad range of biological targets, while the conformationally flexible chair conformation allows substituents to adopt equatorial or axial positions and adapt to diverse binding environments. A comprehensive analysis of FDA-approved pharmaceuticals from 2014 to 2023 confirmed piperidine as the second most common 6-membered heterocycle containing one heteroatom in approved small-molecule drugs over that decade, reflecting its sustained utility as a core scaffold across diverse therapeutic programmes. The ring nitrogen serves as a productive synthetic handle for N-acylation, N-alkylation, reductive amination, and cross-coupling reactions, and the range of piperidine building blocks bearing substituents at the 2-, 3-, and 4-positions, as well as N-functionalised and spirocyclic variants, supports broad structural exploration in both fragment-based and structure-based drug design campaigns.

Prominent in the clinic, examples of Piperidine in approved drugs include; Ibrutinib (Imbruvica, Pharmacyclics/Janssen) an FDA-approved, first-in-class oral covalent inhibitor of Bruton's tyrosine kinase bearing a chiral (3R)-piperidinyl group as the central scaffold element, approved in 2013 for the treatment of B-cell malignancies including mantle cell lymphoma and chronic lymphocytic leukaemia, where it forms an irreversible covalent bond with Cys-481 in the BTK active site. Donepezil (Aricept, Pfizer/Eisai) is a long-established FDA-approved piperidine-containing acetylcholinesterase inhibitor widely used for the symptomatic treatment of Alzheimer's disease, where the piperidine nitrogen coordinates to the active site of the enzyme and is a key contributor to binding affinity and selectivity.

Our range of Piperidines features novel substitutions and the incorporation of synthetically tractable functional groups such as boronic acids and esters, amines, carboxylic acids, ketones, hydroxyls and halogens to enable expedient synthetic strategies. The full range can be found using the substructure feature of our Search tools.